Affymetrix (AFFX) Misses Q4 EPS by 2c, Sales Beat

Affymetrix (NASDAQ: AFFX) reported Q4 EPS of $0.09, $0.02 worse than the analyst estimate of $0.11. Revenue for the quarter came in at $95.6 million versus the consensus estimate of $93.29 million.

For earnings history and earnings-related data on Affymetrix (AFFX) click here.

You May Also Be Interested In

• Rivian reports record Q3 deliveries, beats estimates, shares rise
• Cuprina to buy seven-clinic Singapore healthcare group for S$4M
• Integra LifeSciences stock tumbles after cutting 2026 outlook